Latest
Fosun Pharma shares tumble more than 5% as Hong Kong suspends BioNTech Covid vaccinations
KEY POINTS
Fosun Pharma, BioNTech’s partner in the development and distribution of the Comirnaty Co
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
2
举报
登录后可参与评论
暂无评论